Member Info for barwickman

Yes Longlad noticed Lgp had dropped 25% since it’s last news, I was thinking is 16p a good entry point , I’m just not sure yet it is but surely can’t be far off ?, as for Yooma well what can you say really, few on here had high hopes for it but I was never tempted even at the low price before suspension, no word of them coming back yet is also worrying, one thing the results report from Seed won’t be great reading , think we need a miracle to turn it round before results , but I’ve been told they can happen :-)

But between them they still had to take a loan to get to the next level .

You are most likely right Sam , but it goes to show there not near profit yet , never mind what others are saying about revenue.

I’m on my way back home and I might of missed something , have IMG took part in this loan or is it just Seed, if just Seed I understand the drop today, as IMG / Seed both took part last time.

He will have to ask Quint to tell him what to say, mind you he will have to ask Walter :-)

It would still come under the EDR flagship which IMG and OpenBet are both part of, or will be soon, i just think IMG will have to much on there plate to run Leap and will leave it to OpenBet to run the daily business of Leap Gaming IMHO.

Surely if the sale to IMG was nailed on it could come any day but so far it hasn't, so why not, they know everything they need to know about Leap, OpenBet to be completed soon as you said maybe now Q3, OpenBet said at the start of the year they'd still like to get two more deals done, i could be wrong but id put money on Leap coming under the umbrella of OpenBet, I'm sure OpenBet will be in a better position to facilitate all Leaps customers worldwide than IMG, well that's my take on it for what its worth.

As I’ve said I got rid but not at the top, and yes bought a few when they dipped just under 5 dollars, not sold but got a good start if they do start dropping , I’m sure they can hit 15 dollars soon , how soon not to sure.

Well a goodnight so far for PRGT up around 25%, let’s see if it can hold it and kick on again by the end of the week, surely 5 dollars was the bottom like 4.5p was for Seed ?.

Reefles if Leap is going to stay in the family I can see OpenBet taking charge of all operations of Leap, I’m sure they would be in a better position to facilitate all the other companies that have signed up to Leap as it’s already been stated OpenBet will operate worldwide, as an outsider Playtech but maybe not EDR, IMG preferred choice ?

Talking of dumps Mat how you doing lol

https://ir.portagebiotech.com/news-releases/news-release-details/portage-biotech-summarizes-data-presented-asco-2022-annual/

The rest of the article should be on there website.

Portage Biotech Summarizes Data Presented at ASCO 2022 Annual Meeting Including Updates from Ongoing PORT-2 Study

Preliminary data from the Phase 1/2 trial of PORT-2 demonstrates favorable safety and tolerability as a monotherapy with translational data supporting its mechanism of action

WESTPORT, Conn., June 06, 2022 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company developing therapies to improve patient lives and increase survival by avoiding and overcoming cancer treatment resistance, today announced that the Company presented early data from its Phase 1/2 study of PORT-2 (IMM60), an invariant natural killer T cell (iNKT) agonist for patients with melanoma and non-small cell lung cancer (NSCLC), at the 2022 American Society of Clinical Oncology (ASCO) meeting. Portage also presented three posters on INT230-6 (PORT-1) in collaboration with Intensity Therapeutics.

“We are encouraged by the preliminary safety profile of PORT-2, which is well tolerated when administered intravenously as a monotherapy at all doses tested, including demonstrating single agent activity in one of the two heavily pre-treated patients treated at the mid dose level,” said Dr. Ian Walters, Chief Executive Officer of Portage Biotech. “Additionally, translational analysis confirms that PORT-2 activates iNKT cells, NK cells and dendritic cells, supporting the mechanism of action to stimulate both the adaptive and innate immune system. We plan to continue to evaluate PORT-2 both as a monotherapy and in combination with pembrolizumab and look forward to sharing additional data later in 2022.”

Dr. Walters added, “We are also pleased to share ongoing progress from our collaborators at Intensity Therapeutics including further proof-of-concept in a randomized Phase 2 study for patients with neoadjuvant breast cancer, as well as updates on the ongoing Phase 2 combination studies with Keytruda and Yervoy in collaboration with Merck and BMS.”

The presentation abstracts are available to registrants through the conference platform. The PORT-2 poster will be added to Portage’s website following the conference.

Presentation Details:

PORT-2 Poster Presentation

Track: Developmental Therapeutics – Immunotherapy
Abstract Title: A Phase 1 first-in-human dose finding/randomized phase 2 study of IMM60 and pembrolizumab (PEM) in advanced melanoma and non-small-cell lung cancer (NSCLC) (IMP-MEL).
Presenter/First Author: Nicholas Coupe, MBBS Oxford University Hospital Oxford, United Kingdom
Abstract Number: 382017
Poster: 237

PORT-1 Presentations

Track: Sarcoma
Abstract Title: INT230-6 monotherapy and in combination with ipilimumab (IPI) across a broad spectrum of refractory soft tissue sarcomas (STS) [Intensity IT-01; BMS#CA184-592].
Presenter/First Author: Matthew Ingham, MD
Abstract Number: 11515
Poster: 420

Track: Developmental Therapeutics – Immunotherapy
Abstract Title: Effect of intratumoral INT23

They wont get back in if they've missed the bus lol

I said the same thing twice, so it must be good :-), but sure you get the point I'm making.

'Pivotal moment' as new drug is found to boost breast cancer survival
https://mol.im/a/10887723
From what I’m reading don’t think Intensity Therapeutics are that far behind from what I’m reading , awaiting news soon , all good for PRTG/Seed if successful , GLA

Sorry 1st line should of started, Are you saying you were the only one that predicted these moves up.

Are you saying you predicted these moves up because if you are your wrong again, the move up this time and with the possible Leap sale everyone on here has a higher price target not just you, remember credibility works both ways, did you predict the 30-6p 15-6p and the 12.5-5p or did you see no downside, better to stick to facts. Well GLA and lets see if we all get what we want in June regarding Leap or whenever the news come :-), enjoy the long weekend.

No ones talking about red,, but you've appeared to put the cream on top of the cak lol